1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Announces Hiring of Barry Blake to Expand Its Healthcare Investment Banking Group

Our Firm

June 12, 2014

Guggenheim Securities Announces Hiring of Barry Blake to Expand Its Healthcare Investment Banking Group

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of Barry Blake as a Senior Managing Director. Mr. Blake will focus on advising healthcare services companies and will commence work at Guggenheim in September 2014.

“We are very pleased to welcome Barry to the team,” said Mark Van Lith, Head of Investment Banking at Guggenheim Securities. “Barry is a trusted adviser to his clients. Barry’s strong relationships and deep sector expertise will contribute meaningfully to our healthcare franchise.”

Most recently, Mr. Blake was the Head of Global Healthcare Mergers and Acquisitions for Citigroup. Prior to that, he was in the M&A and Healthcare groups at JP Morgan and Lehman Brothers.

Mr. Blake has extensive relationships and experience in healthcare services. His recent transaction experience includes: Express-Scripts acquisition of Medco, Amsurg's acquisition of Sheridan Healthcare, the sale of Rehabcare Group to Kindred Healthcare, and Labcorp's acquisition of Genzyme Genetics.

Mr. Blake received his BS from Hendrix College and his MBA from Tuck School of Business.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $210 billion in assets under management. The firm provides asset management, investment banking and capital markets services, insurance services, institutional finance and investment advisory solutions to institutions, governments and agencies, corporations, investment advisors, family offices and individuals. Guggenheim Partners is headquartered in New York and Chicago and serves clients around the world from more than 25 offices in eight countries. For more information about Guggenheim Partners, visit www.guggenheimpartners.com.


Media Contacts

Thomas S. Mulligan
Sitrick And Company
310.367.6567
thomas_mulligan@sitrick.com

Terry Fahn
Sitrick And Company
310.788.2850
terry_fahn@sitrick.com



July 17, 2018

Whitney Ijem Joins Guggenheim Securities as Biotech Analyst

Guggenheim Securities announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.

Read More

July 12, 2018

Guggenheim Securities Hires Jordan Bliss to Expand Healthcare Investment Banking Group

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jordan Bliss will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group. Mr. Bliss will focus on advising companies in the life sciences sector and will be based in Guggenheim’s San Francisco office.

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.